23 June 2015
TreVia Digital Health and D-EYE Partner to Enable
TreVia’s HIPAA-compliant cloud platform will power the D-EYE ImageVaultTM, increasing remote access to retinal evaluations for early diagnosis and sight-saving treatmen
OVERLAND PARK, KS; PADOVA, ITALY – June 23, 2015 – TreVia Digital Health (TreVia), innovators in cutting-edge technology solutions for the diabetes care industry, and D-EYE Srl, a pioneering developer of advanced devices for mass health screenings and data collection, announced today a strategic partnership in which D-EYE will use TreVia’s industry-best cloud-based data management platform and technology to power the D-EYE ImageVault™.
The secure TreVia platform, originally created to treat and manage diabetes using telemedicine and other care management software technology, will host and manage the D-EYE ImageVault for storing, analyzing and sharing images captured by the D-EYE portable retinal imaging system. This collaboration will leverage TreVia’s HIPAA-compliant cloud service to enable account set-up, workflow management, sharing and archiving D-EYE videos, still images and corresponding data for instant access by ophthalmologists, optometrists, general practitioners and other medical specialists, facilitating wide-spread eye screening from anywhere.
The first truly portable ophthalmoscope capable of recording and transmitting images of the eye, the D-EYE attaches to a smartphone (currently Apple or Samsung), creating a fundus camera which can capture high-definition video and still images of the interior of the eye for health screening and evaluation. The lightweight and easy-to-use D-EYE device is ideal for screening and possible detection of a variety of eye disorders including diabetic retinopathy, glaucoma, macular degeneration, and many other eye conditions and abnormalities.
“With their innovative cloud platform and data analytics capabilities, TreVia Digital Health is creating new possibilities for telemedicine, remote health care delivery and collaboration across the health care delivery and medical community,” said D-EYE CEO Richard Sill. “Our global vision care customers require a secure cloud platform that meets medical standards for image storage and handling, as well as patient privacy, and the TreVia solution delivers. We are thrilled to partner with them to further expand the screening and diagnostic support benefits of the D-EYE portable retinal imaging system.”
D-EYE-generated images and videos will be stored in the TreVia-powered D-EYE ImageVault and accessible to providers where and when needed for analysis, comparison and diagnosis, allowing the entire care team to effectively engage in the patient’s health treatment plan. The telemedicine services that the partnership enables will prove particularly beneficial in rural locales, developing countries and other underserved areas, bringing critical eye screening services and access to retinal specialists to people in need in the most remote locations across the globe.
“TreVia is excited about the partnership with D-EYE as it provides a disruptive technological leap in telemedicine to provide retinal screening to healthcare consumers globally, including those in rural and impoverished regions where diabetes is prevalent,” added Maureen Peszko, President and COO at TreVia Digital Health. “It is our mission ultimately to provide better patient outcomes by advancing a new level of digital collaboration that enables us to detect issues early, preserve vision, reduce complex procedures and lower healthcare costs.”
The D-EYE ImageVault cloud service platform will be available to D-EYE users later this year.
About TreVia Digital Health
TreVia Digital Health provides an innovative, holistic and conveniently accessible diabetes care experience that uses technology-enabled services, including digital diabetes screenings using telemedicine, for the prevention of chronic and polychronic diabetic complications. TreVia measurably impacts diabetes outcomes by identifying issues early, using technology to connect the best specialists for virtual evaluation and treatment while preventing complications, resulting in an improved patient experience and overall lower health care costs.
Today, TreVia provides diabetes screening, including retinopathy and peripheral neuropathy, along with glucose monitoring and mapping, and affective computing for patient engagement including interval learning, behavior evaluation and lifestyle coaching for those affected by diabetes and pre-diabetes conditions. For more information about Trevia Digital Health, LLC., please visit www.treviadigitalhealth.com.
Founded in 2014, with offices in Padova, Italy, Pasadena, CA, and Boston, MA, D-EYE Srl offers a "digital eye" into the state of the human body. The company designs and manufactures mobile sensing and examination devices, along with companion applications, that make possible mass health screenings and data collection to improve access to vital health examination services. D-EYE also develops and operates cloud-based Platform-as-a-Service (PaaS) systems that enable telehealth applications, and aggregate and analyze health-screening data to provide insight into individual conditions as well as trends across patient populations.
The company's first product, developed in part with a grant from the Fondazione Cottino and with support from the University of Brescia (Italy), the revolutionary D-EYE Portable Retinal Imaging System focuses on eye care; subsequent mobile-health products and services will target screening and evaluation of other medical conditions and pathologies. D-EYE was created by Si14 SpA, a visionary original design and development laboratory for novel technology products that enhance the way we live, work and play. For more information, please visit www.d-eyecare.com.